Over 4,000 people enroll in Phase II trial of local COVID-19 vaccine
03/30/2021 08:30 PM
Over 4,000 people in Taiwan have enrolled in the second-stage clinical trial of a domestic COVID-19 vaccine, of whom around 3,700 have already received an injection, the vaccine's developer, Medigen Vaccine Biologics Corp. (MVC), announced Tuesday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Business
Customs service details measures to help typhoon-hit companies
07/07/2025 07:13 PM - Society
Agricultural losses from Typhoon Danas at least NT$250 million
07/07/2025 06:31 PM - Business
Taiwan-U.S. tariff talks still ongoing: Economics minister
07/07/2025 06:14 PM - Society
Taiwan lifts sea warning for Tropical Storm Danas, warns heavy rain
07/07/2025 05:55 PM - Society
Domestic Taiwanese flights resume following Danas disruption
07/07/2025 05:43 PM